Novel pharmacological targets for the treatment of aortic stenosis
Calcific aortic stenosis (AS) is the most prevalent valvular lesion requiring intervention worldwide and is associated with substantial morbidity and mortality. Despite its growing global burden, no pharmacological therapy has been proven to prevent the onset or slow the progression of AS, leaving valve replacement a...